SAN DIEGO, May 31, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) has elected Patricia Nasshorn to its board of directors. Ms. Nasshorn replaces former board member Ruth A. Wooden, who resigned to pursue other interests.
Ms. Nasshorn brings to Women First extensive expertise in the pharmaceutical industry and women's health care in corporate development, marketing and business strategy. Her experience includes a recent four-year tenure as president of Unilever's women's health, Unipath division, and a diverse range of senior executive positions with Johnson & Johnson, Merck & Company, Inc. and Bristol-Myers Squibb.
Ms. Nasshorn holds an MBA, Marketing and Finance, and a BBA, Marketing and Management, both from Temple University.
"It is with great pleasure that we announce Pat Nasshorn's election to our board," said Women First HealthCare chairman, president and CEO, Edward F. Calesa. "Pat will be an excellent complement to our board and our company for a number of reasons. She shares our passion and strong interest in women's health issues. She brings 25 years of premier women's health care and consumer industry insight, experience and success to Women First. She has a proven track record in growing revenue and market share in women's health pharmaceuticals, diagnostics and OTCs. We are confident her abilities will advance our growth strategy while benefiting our Pharmaceutical and Consumer Divisions."
About Women First HealthCare, Inc.
Women First HealthCare, Inc. (Nasdaq:WFHC) is a San Diego-based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products -- the Company's primary emphasis -- and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians. Further information about Women First HealthCare can be found online at www.womenfirst.com, About Us and Investor Relations.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to various risks, and Women First HealthCare, Inc. cautions you that any forward-looking information is not a guarantee of future performance. Women First HealthCare, Inc. disclaims any intent or obligation to update these forward-looking statements. Actual results could differ materially due to a number of factors, including (i) we have incurred significant losses since we were founded in November 1996, and if midlife women do not use, and their clinicians do not recommend, the products we offer, we will experience losses in the future; (ii) there is a limited market awareness of our Company and the products and services we offer; (iii) we may not be able to identify appropriate acquisition, licensing, or co-promotion candidates in the future or to take advantage of the opportunities we identify; (iv) we and our products face significant competition; (v) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (vi) we are dependent on single sources of supply for all of the products we offer; (vii) reduced consumer confidence could adversely affect sales by our Consumer Business Division; (viii) we have incurred significant debt obligations which will require us to make debt service payments in the future; and (ix) additional factors set forth in the Company's Securities and Exchange Commission filings including its Annual Report on Form 10-K for the period ended December 31, 2001 and its Form 10-Q for the period ended March 31, 2002.